MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Cash & Current Investments (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Cash & Current Investments came in at $65.9 million in Q4 2025, down 36.4% YoY from $103.7 million in Q4 2024, and up 344.25% on a QoQ basis from $14.8 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Cash & Current Investments (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Cash & Current Investments data on file, last reported at $65.9 million in Q4 2025.

  • Quarterly Cash & Current Investments fell 36.4% year-over-year to $65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.9 million (down 36.4% YoY) and the FY2025 annual result came in at $65.9 million, down 36.4% from the prior year.
  • Cash & Current Investments improved to $65.9 million in Q4 2025, from $14.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $199.4 million in Q1 2021 to a low of $14.8 million in Q3 2025.
  • A 5-year average of $102.8 million and a median of $108.7 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments surged 94.14% — and 2025, when it tumbled 88.13%.
  • Tracing MGTX's Cash & Current Investments over 5 years: stood at $137.7 million in 2021, then retreated by 16.11% to $115.5 million in 2022, then increased by 13.1% to $130.6 million in 2023, then slipped by 20.66% to $103.7 million in 2024, then plunged by 36.4% to $65.9 million in 2025.
  • The last three Cash & Current Investments figures came in at $65.9 million (Q4 2025), $14.8 million (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 143.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143.17 Mn
Dec 31, 2025 65.93 Mn
Sep 30, 2025 14.84 Mn
Jun 30, 2025 32.17 Mn
Mar 31, 2025 66.52 Mn
Dec 31, 2024 103.66 Mn
Sep 30, 2024 125.03 Mn
Jun 30, 2024 101.03 Mn
Mar 31, 2024 120.27 Mn
Dec 31, 2023 130.65 Mn
Sep 30, 2023 64.40 Mn
Jun 30, 2023 92.77 Mn
Mar 31, 2023 68.78 Mn
Dec 31, 2022 115.52 Mn
Sep 30, 2022 114.71 Mn
Jun 30, 2022 72.11 Mn
Mar 31, 2022 113.78 Mn
Dec 31, 2021 137.70 Mn
Sep 30, 2021 143.63 Mn
Jun 30, 2021 172.56 Mn